Nov 16th 2015, 11:00 am ET

Join us Monday, November 16 at 11am eastern for a one on one conversation between PPMD President Pat Furlong and Dr. Tim Franson, Chief Medical Officer of Your Encore and former VP of Global Regulatory Affairs and Drug Safety at Eli Lilly, to discuss what we can expect out of the upcoming Advisory Committee meetings with the FDA. Not only will Pat and Tim discuss the kinds of recommendations that can come out of these meetings, but they will also examine how these recommendations potentially affect the FDA’s ultimate decision on whether or not to approve potential therapies.

With the upcoming BioMarin Ad Comm on 11/24 and a Sarepta Ad Comm likely early in the New Year, PPMD will continue to bring you updates and information to help better inform the community on this complicated approval and access processes.

Speakers:

• Pat Furlong, PPMD President
• Dr. Tim Franson, Chief Medical Officer of Your Encore and former VP of Global Regulatory Affairs and Drug Safety at Eli Lilly

To Participate:

1. Visit ReadyTalk.com and use participant code 9449985. (Be sure to test your computer beforehand)
2. Audio Dial-In Information:
   • U.S. & Canada: Dial 1.866.740.1260 and use the Access Code 9449985
   • Outside the U.S. and Canada: Lookup your number

Submit Questions:

Please submit questions in advance to info@parentprojectmd.org (subject line: Ad Comms Webinar) by Friday, 11/13 at noon eastern.